Northwest Biotherapeutics reported $31.8M in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
Agenus USD 169.66M 146.06M Dec/2025
AstraZeneca USD 25.96B 177M Mar/2026
Bristol-Myers Squibb USD 42.15B 698M Mar/2026
Eisai JPY 134.78B 12M Mar/2026
Infinity Pharmaceuticals USD 0 0 Jun/2022
Merck USD 46.67B 77M Mar/2026
Northwest Biotherapeutics USD 31.8M 11.49M Sep/2025
Pfizer USD 60.57B 1.08B Mar/2026
Plus Therapeutics USD 3.79M 322K Dec/2022
Roche Holding CHF 27.43B 966M Dec/2025